Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Hims & Hers Health Inc shares valued at $3,433,162 were sold by Dudum Andrew on Oct 01 ’24. At $18.18 per share, Dudum Andrew sold 188,888 shares. The insider’s holdings dropped to 67,015 shares worth approximately $1.15 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Dudum Andrew sold 144,444 shares, netting a total of over 2,631,394 in proceeds. Following the sale of shares at $18.22 each, the insider now holds 651,046 shares.
Before that, Boughton Soleil had sold 2,339 shares from its account. In a trade valued at $43,272, the Chief Legal Officer traded Hims & Hers Health Inc shares for $18.50 each. Upon closing the transaction, the insider’s holdings decreased to 2,339 shares, worth approximately $2.99 million.
As published in their initiating research note from Needham on August 22, 2024, Hims & Hers Health Inc [HIMS] has been a Buy and the price target has been revised to $24. Analysts at Imperial Capital downgraded the stock from ‘”an Outperform”‘ to ‘”an In-line”‘ outlook in a report released in early August. As of May 22, 2024, Citigroup has decreased its “Buy” rating to a “Neutral” for HIMS. Earlier on April 16, 2024, Jefferies downgraded its rating. Their new recommendation was “a Hold” for HIMS stock which previously was a “a Buy”.
Analyzing HIMS Stock Performance
During the last five days, there has been a drop of approximately -3.27%. Over the course of the year, Hims & Hers Health Inc shares have jumped approximately 92.47%. Shares of the company reached a 52-week high of $25.74 on 06/18/24 and a 52-week low of $8.09 on 01/05/24. A 50-day SMA is recorded $16.80, while a 200-day SMA reached $15.08. Nevertheless, trading volume fell to 25.26 million shares from 10.06 million shares the previous day.
Support And Resistance Levels for Hims & Hers Health Inc (HIMS)
According to the 24-hour chart, there is a support level at 16.32, which, if violated, would cause prices to drop to 15.52. In the upper region, resistance lies at 17.66. The next price resistance is at 18.19. RSI (Relative Strength Index) is 51.11 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 1.17, which suggests the price will increase in the coming days. Percent R is at 61.43%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
